These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 16105118)

  • 1. Selective reduction of anti-Helicobacter pylori IgG subclass antibody in gastric carcinoma.
    Ren Z; Borody T; Pang G; Li LC; Dunkley M; Clancy R
    J Gastroenterol Hepatol; 2005 Sep; 20(9):1338-43. PubMed ID: 16105118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response of IgG1 and IgG2 subclasses to Helicobacter pylori in subjects with chronic inflammation of the gastric mucosa, atrophy and gastric cancer in a country with high Helicobacter pylori infection prevalence.
    Vorobjova T; Ren Z; Dunkley M; Clancy R; Maaroos HI; Labotkin R; Kull K; Uibo R
    APMIS; 2006 May; 114(5):372-80. PubMed ID: 16725014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Helicobacter pylori infection on the humoral immune response to MUC1 peptide in patients with chronic gastric diseases and gastric cancer.
    Klaamas K; Kurtenkov O; von Mensdorff-Pouilly S; Shljapnikova L; Miljukhina L; Brjalin V; Lipping A
    Immunol Invest; 2007; 36(4):371-86. PubMed ID: 17691020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue IgA antibody against Helicobacter pylori in patients with gastroduodenal diseases: comparison with bacterial culture, serum IgG antibody, and [13C]Urea breath test.
    Matsukura N; Onda M; Tokunaga A; Kato S; Kyono S; Yamashita K
    J Clin Gastroenterol; 1995; 21 Suppl 1():S146-50. PubMed ID: 8775008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of anti-Helicobacter pylori IgG antibody titer following eradication of Helicobacter pylori infection.
    Koizumi W; Tanabe S; Imaizumi H; Hibi K; Kida M; Ohida M; Okayasu I; Saigenji K
    Hepatogastroenterology; 2003; 50(49):293-6. PubMed ID: 12630044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti Helicobacter pylori IgG and IgA response in patients with gastric cancer and chronic gastritis.
    Manojlovic N; Babic D; Filipovic-Ljeshovic I; Pilcevic D
    Hepatogastroenterology; 2008; 55(82-83):807-13. PubMed ID: 18613460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. gammadelta T cells increase with gastric mucosal interleukin (IL)-7, IL-1beta, and Helicobacter pylori urease specific immunoglobulin levels via CCR2 upregulation in Helicobacter pylori gastritis.
    Futagami S; Hiratsuka T; Suzuki K; Kusunoki M; Wada K; Miyake K; Ohashi K; Shimizu M; Takahashi H; Gudis K; Kato S; Tsukui T; Sakamoto C
    J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):32-40. PubMed ID: 16706809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seroreactivity to specific antigens of Helicobacter pylori infection is associated with an increased risk of the dyspeptic gastrointestinal diseases.
    Chomvarin C; Ottiwet O; Hahnvajanawong C; Intapan PM; Wongwajana S
    Int J Infect Dis; 2009 Sep; 13(5):647-54. PubMed ID: 19233700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IgG subclass antibodies against Helicobacter pylori heat-stable antigens in normal persons and in dyspeptic patients.
    Andersen LP; Gaarslev K
    APMIS; 1992 Aug; 100(8):747-51. PubMed ID: 1520486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Helicobacter pylori-induced peptic ulcer disease is associated with inadequate regulatory T cell responses.
    Robinson K; Kenefeck R; Pidgeon EL; Shakib S; Patel S; Polson RJ; Zaitoun AM; Atherton JC
    Gut; 2008 Oct; 57(10):1375-85. PubMed ID: 18467372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IgG subclass responses in childhood Helicobacter pylori duodenal ulcer: evidence of T-helper cell type 2 responses.
    Campbell DI; Pearce MS; Parker L; Thomas JE
    Helicobacter; 2004 Aug; 9(4):289-92. PubMed ID: 15270742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased IgA antibody production in the stomach of gastric adenocarcinoma patients.
    Quiding-Järbrink M; Sundström P; Lundgren A; Hansson M; Bäckström M; Johansson C; Enarsson K; Hermansson M; Johnsson E; Svennerholm AM
    Clin Immunol; 2009 Jun; 131(3):463-71. PubMed ID: 19249247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Helicobacter pylori infection in gastric carcinoma.
    Kato T; Saito Y; Niwa M; Inoue H; Motoyama N; Ogoshi K; Nashimoto A; Sasaki J; Sato T; Asaka M
    Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S93-6. PubMed ID: 7735944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The number of Foxp3-positive regulatory T cells is increased in Helicobacter pylori gastritis and gastric cancer.
    Jang TJ
    Pathol Res Pract; 2010 Jan; 206(1):34-8. PubMed ID: 19819643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum antibody positivity for distinct Helicobacter pylori antigens in benign and malignant gastroduodenal disease.
    Schumann C; Triantafilou K; Rasche FM; Möricke A; Vogt K; Triantafilou M; Hahn P; Schneider EM; Lepper PM
    Int J Med Microbiol; 2006 Aug; 296(4-5):223-8. PubMed ID: 16600680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age and severity of mucosal lesions influence the performance of serologic markers in Helicobacter pylori-associated gastroduodenal pathologies.
    Camorlinga-Ponce M; Flores-Luna L; Lazcano-Ponce E; Herrero R; Bernal-Sahagún F; Abdo-Francis JM; Aguirre-García J; Muñoz N; Torres J
    Cancer Epidemiol Biomarkers Prev; 2008 Sep; 17(9):2498-504. PubMed ID: 18768521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-cardia gastric adenocarcinoma and Helicobacter pylori infection.
    Archimandritis A; Bitsikas J; Tjivras M; Anastasakou E; Tsavaris N; Kalogeras D; Davaris P; Fertakis A
    Ital J Gastroenterol; 1993; 25(7):368-71. PubMed ID: 8280897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The local and systemic T-cell response to Helicobacter pylori in gastric cancer patients is characterised by production of interleukin-10.
    Lundin BS; Enarsson K; Kindlund B; Lundgren A; Johnsson E; Quiding-Järbrink M; Svennerholm AM
    Clin Immunol; 2007 Nov; 125(2):205-13. PubMed ID: 17826353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of IgG antibody titer against Helicobacter pylori.
    Tatemichi M; Sasazuki S; Inoue M; Tsugane S;
    Helicobacter; 2009 Jun; 14(3):231-6. PubMed ID: 19702853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preservation of gastric acid secretion may be important for the development of gastroesophageal junction adenocarcinoma in Japanese people, irrespective of the H. pylori infection status.
    Inomata Y; Koike T; Ohara S; Abe Y; Sekine H; Iijima K; Ariizumi K; Yamagishi H; Kitagawa Y; Imatani A; Shimosegawa T
    Am J Gastroenterol; 2006 May; 101(5):926-33. PubMed ID: 16573782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.